UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000049507
Receipt number R000056125
Scientific Title RelatIonship between implementation of evidence-based and suppoRtive ICU care and outcomes of patients with acute respiratory distress syndrome
Date of disclosure of the study information 2022/12/01
Last modified on 2022/11/16 12:06:56

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

RelatIonship between implementation of
evidence-based and suppoRtive ICU care and
outcomes of patients with acute respiratory distress syndrome

Acronym

The ICU LIBERATION study

Scientific Title

RelatIonship between implementation of
evidence-based and suppoRtive ICU care and
outcomes of patients with acute respiratory distress syndrome

Scientific Title:Acronym

The ICU LIBERATION study

Region

Japan Asia(except Japan) North America
South America Australia Europe
Africa


Condition

Condition

Acute Respiratory Distress Syndrome

Classification by specialty

Medicine in general Surgery in general Operative medicine
Emergency medicine Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aims to investigate the epidemiology and treatments given to the patients and evaluate the implementation of evidence based ICU care and its association with the outcomes of patients with acute respiratory distress syndrome admitted to the ICU. The contents of mechanical ventilation settings, respiratory conditions, and the evidence -based ICU care, such as analgesia, sedation, rehabilitation, and nutrition, given to the patients will be collected in a daily basis.
Aim 1: Epidemiology
Aim 2: Treatments
Aim 3: Evidence-based ICU care

Basic objectives2

Others

Basic objectives -Others

Aim 1: Epidemiology
Aim 2: Treatments
Aim 3: Evidence-based ICU care

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The following items will be collected in this study
1) Epidemiology: mortality (survival rate), length of ICU/hospital stay, mechanical ventilation period, etc.
2) Treatment: the achievement of lung-protective ventilation, mechanical ventilation setting, prone positioning, neuromuscular blockade, dialysis, etc.
3) Evidence-based ICU care
3-1) ABCDEF bundle implementation ratio
3-2) Evaluation of PADIS and its compliance status
3-3) Nutrition
3-4) ICU diary
3-5) The presence or absence of physical restraints
3-6) Sleep, etc.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients on an invasive or non-invasive ventilator within 24 hours of ICU admission

2) Patients who are expected to be on an invasive and/or non-invasive ventilator for more than 48 hours in total

3) Patients who meet the diagnosis of ARDS within 24 hours of ICU admission

Key exclusion criteria

1) Patients who are younger than 16 years old
2) Patients with terminal conditions at the time of ICU admission
3) Patients who have been admitted to the ICU with a terminal care policy or who are expected to be admitted to the ICU with a terminal care policy within 24 hours of admission to the ICU
4) Patients who have expressed their refusal to have their clinical data used in research.

Target sample size

1000


Research contact person

Name of lead principal investigator

1st name Keibun
Middle name
Last name Liu

Organization

The Japanese Society for Early Mobilization

Division name

LIBERATION Study Steering Committee

Zip code

1020073

Address

2F, Plarel Building, 1-2-12, Kudan-kita 1-chome, Chiyoda-ku, Tokyo 102-0073, Japan

TEL

03-3556-5585

Email

keiliu0406@gmail.com


Public contact

Name of contact person

1st name Keibun
Middle name
Last name Liu

Organization

The Japanese Society for Early Mobilization

Division name

LIBERATION Study Steering Committee

Zip code

1020073

Address

2F, Plarel Building, 1-2-12, Kudan-kita 1-chome, Chiyoda-ku, Tokyo 102-0073, Japan

TEL

03-3556-5585

Homepage URL


Email

keiliu0406@gmail.com


Sponsor or person

Institute

The Japanese Society for Early Mobilization

Institute

Department

Personal name



Funding Source

Organization

Japanese association of acute medicine, Drager

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Japanese Society for Early Mobilization

Address

2F, Plarel Building, 1-2-12, Kudan-kita 1-chome, Chiyoda-ku, Tokyo 102-0073, Japan

Tel

03-3556-5585

Email

winegood21@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2022 Year 10 Month 30 Day

Date of IRB

2022 Year 11 Month 10 Day

Anticipated trial start date

2023 Year 06 Month 01 Day

Last follow-up date

2024 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2022 Year 11 Month 15 Day

Last modified on

2022 Year 11 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056125


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name